DRTS
Price
$3.14
Change
+$0.28 (+9.79%)
Updated
Feb 23, 6:59 PM EST
30 days until earnings call
TCRX
Price
$6.76
Change
-$0.06 (-0.88%)
Updated
Feb 23, 6:59 PM EST
10 days until earnings call
Ad is loading...

Compare predictions DRTS vs TCRX

Header iconDRTS vs TCRX Comparison
Open Charts DRTS vs TCRXBanner chart's image
Alpha Tau Medical
Price$3.14
Change+$0.28 (+9.79%)
Volume$31.48K
CapitalizationN/A
TScan Therapeutics
Price$6.76
Change-$0.06 (-0.88%)
Volume$57.12K
CapitalizationN/A
View a ticker or compare two or three
DRTS vs TCRX Comparison Chart

Loading...

DRTSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DRTS vs. TCRX commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a StrongBuy and TCRX is a StrongBuy.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (DRTS: $3.14 vs. TCRX: $6.76)
Brand notoriety: DRTS and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 109% vs. TCRX: 65%
Market capitalization -- DRTS: $218.15M vs. TCRX: $323.29M
DRTS [@Biotechnology] is valued at $218.15M. TCRX’s [@Biotechnology] market capitalization is $323.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $552.93B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 0 green FA rating(s).

  • DRTS’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, TCRX is a better buy in the long-term than DRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • DRTS’s TA Score: 6 bullish, 3 bearish.
  • TCRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than TCRX.

Price Growth

DRTS (@Biotechnology) experienced а +2.61% price change this week, while TCRX (@Biotechnology) price change was -0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

DRTS is expected to report earnings on May 22, 2024.

TCRX is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for DRTS with price predictions.
OPEN
A.I.dvisor published
a Summary for TCRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TCRX($323M) has a higher market cap than DRTS($218M). TCRX YTD gains are higher at: 15.952 vs. DRTS (4.319). DRTS has higher annual earnings (EBITDA): -33.72M vs. TCRX (-78.88M). TCRX has more cash in the bank: 215M vs. DRTS (87.2M). DRTS has less debt than TCRX: DRTS (6.05M) vs TCRX (87M). TCRX has higher revenues than DRTS: TCRX (16.9M) vs DRTS (0).
DRTSTCRXDRTS / TCRX
Capitalization218M323M67%
EBITDA-33.72M-78.88M43%
Gain YTD4.31915.95227%
P/E RatioN/AN/A-
Revenue016.9M-
Total Cash87.2M215M41%
Total Debt6.05M87M7%
TECHNICAL ANALYSIS
Technical Analysis
DRTSTCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
DRTSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGUCX13.270.06
+0.45%
Virtus Duff & Phelps Global Infras C
FSQZX9.200.01
+0.11%
Fidelity Advisor Sustainable Intl Eq Z
FACPX37.900.03
+0.08%
Fidelity Advisor Consumer Discret M
EKBYX12.58-0.01
-0.08%
Allspring Diversified Cap Bldr Inst
ASLDX113.18-0.09
-0.08%
American Century Select G

DRTS and

Correlation & Price change

A.I.dvisor tells us that DRTS and HOOK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRTS and HOOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+9.41%
HOOK - DRTS
25%
Poorly correlated
-2.42%
COGT - DRTS
24%
Poorly correlated
-16.87%
KRYS - DRTS
23%
Poorly correlated
-0.56%
MTEM - DRTS
23%
Poorly correlated
+3.63%
ARWR - DRTS
23%
Poorly correlated
+4.62%
More

TCRX and

Correlation & Price change

A.I.dvisor tells us that TCRX and IMRN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TCRX and IMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-0.88%
IMRN - TCRX
24%
Poorly correlated
-2.33%
ZYME - TCRX
23%
Poorly correlated
+0.08%
CKPT - TCRX
23%
Poorly correlated
+4.26%
VYNE - TCRX
22%
Poorly correlated
+4.15%
RNAC - TCRX
22%
Poorly correlated
+1.39%
More